semaxanib

(3E)-3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylen]-1,3-dihydro-2H-indol-2-on

(3E)-3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one

(3E)-3-[(3,5-Diméthyl-1H-pyrrol-2-yl)méthylène]-1,3-dihydro-2H-indol-2-one

(3E)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one

1,3-Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one

194413-58-6

204005-46-9

2H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-, (3E)-

MFCD01940922

semaxanib

[Wiki]

(3E)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one

(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]indolin-2-one

(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one

(E)-3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one

1421-68-7

194413-57-5

2H-INDOL-2-ONE, 3-[(3,5-DIMETHYL-1H-PYRROL-2-YL)METHYLENE]-1,3-DIHYDRO-,(3E)-

3-(3,5-Dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one

71009-17-1

95%

Semaxinib

Semaxinib(SU 5416)